Welcome To The Stem Cell Therapeutics HUB On AGORACOM

Stem Cell is a public biotechnology company focused on the development and commercialization of drug-based therapies to treat central nervous system diseases.

Free
Message: NR: Stem Cell Therapeutics Corp. Announces the Issuance of United States Patent

I have 2 thoughts about why..

My first scenerio is as you say.. to shift focus from the PhaseIIb on to MS.(this I doubt is the reason IMO)

My other scenerio is they are alerting investors in a very subtle way and setting the stage for more good news to try their absolute best to get those .50 cent warrants exercised by the end of the month! Its going to take a lot of work now but is still very possible.

Share
New Message
Please login to post a reply